Development of a novel hyaluronic acid membrane for the treatment of ocular surface diseases
Abstract Ocular surface diseases (OSD) can cause serious visual deterioration and discomfort. Commercial artificial tear solution containing hyaluronic acid (HA) show excellent biocompatibility and unique viscoelastic characteristics. Here, we developed a novel HA membrane (HAM) by chemical crosslin...
Enregistré dans:
Auteurs principaux: | Dong Ju Kim, Mi-Young Jung, Ha-Jin Pak, Joo-Hee Park, Martha Kim, Roy S. Chuck, Choul Yong Park |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/effb8fb41b86493b907ce6bb2b80c591 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Evaluation of moxifloxacin-induced cytotoxicity on human corneal endothelial cells
par: Joo-Hee Park, et autres
Publié: (2021) -
Effect of Nitric Oxide on Human Corneal Epithelial Cell Viability and Corneal Wound Healing
par: Joo-Hee Park, et autres
Publié: (2017) -
An Evaluation of the in vivo Safety of Nonporous Silica Nanoparticles: Ocular Topical Administration versus Oral Administration
par: Martha Kim, et autres
Publié: (2017) -
Efficacy of carbomer sodium hyaluronate trehalose vs hyaluronic acid to improve tear film instability and ocular surface discomfort after cataract surgery
par: Caretti L, et autres
Publié: (2019) -
Phytosome-hyaluronic acid systems for ocular delivery of L-carnosine
par: Abdelkader H, et autres
Publié: (2016)